BRANFORD, Conn. and VIENNA, Nov. 4, 2013 /PRNewswire-iReach/ -- BioXcel to Showcase its Revolutionary PharmGPS™ Platform
at the International Partnering Conference, BioEurope 2013
--Converging Big Data and the Pharma World--
Branford, CT, USA/Vienna, Austria, November 04, 2013 BioXcel Corporation, a leading biopharmaceutical consulting and technology firm, today announced that it will present a live demonstration of its newly launched analytics platform, PharmGPS™, at the 19th Annual International Partnering Conference—BioEurope (Vienna, Austria, November 4th – 7th).
Showcased earlier this year at the Phacilitate Boston Leaders' Forum 2013, PharmGPS™ is tailor-made for the biopharmaceutical industry, combining both scale and customized decision support in real time. Speaking at the launch, BioXcel's Chairman, Dr. Vimal Mehta, said "PharmGPS™represents a game changer for the biopharmaceutical industry by bridging the innovation to commercialization gap. From in-depth indication blueprints to global pipeline performance benchmarking and market forecasting, this cloud-based platform assists key stakeholders navigating through the decision making paradigm in the rapidly evolving healthcare ecosystem."
Built on a million man-hours of analytics encompassing major health-care burdens, commercially validated frameworks, deep domain expertise, and proprietary processes, the PharmGPS™decision engine provides the flexibility to combine internal or partner's confidential information with the latest worldwide therapeutic area assessments via customized, downloadable "apps" -–all backed by BioXcel's expert consulting and technology services.
"Having been in the consulting space for seven years, BioXcel has seen its recommendations deliver rich dividends for our clients, ranging from big pharma to fast growth biotech companies," said Dr. Krishnan Nandabalan, BioXcel's, President and CEO. "With PharmGPS™, our value proposition is now further enhanced by providing an interactive analytics engine to empower therapeutic area franchises."
Headquartered in Branford, CT, BioXcel Corporation is a leading, analytics-based biopharmaceutical consulting company providing 360° decision support solutions through its expert services and analytics-enabled platform, PharmGPS™. BioXcel has grown steadily as a valued partner during the last seven years, serving the biopharmaceutical industry exclusively.
Visit www.bioxcel.com, or www.pharmgps.com for more details. Connect with PharmGPS on Twitter:@PharmGPS;
Contact:Dr. Krishnan Nandabalan780 East Main StreetBranford, CT 06405http://www.bioxcel.comPhone: 203 433 4086 Email: knandabalan@bioxcel.com
Media Contact: Krishnan Nandabalan, BioXcel Corporation, 203-606-3000, knandabalan@bioxcel.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE BioXcel Corporation
RELATED LINKShttp://www.bioxcel.com
| < Prev | Next > |
|---|
